REZDIFFRA

 (resmetirom)

MADRIGAL PHARMCEUTICALS

Composition:⁴

60 mg, 80 mg, 100 mg

Indications:⁴

REZDIFFRA is indicated in conjunction with diet and exercise for the treatment of non- alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).

Reference

4. REZDIFFRA US Prescribing Information 2024. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217785s000lbl.pdf